Skip to main content
Equibles
ALAB logo

ALAB · Astera Labs, Inc. · Analyst Estimates

Track ALAB — free

Use ALAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$179.47 -43.80 (-19.62%) At close · Nov 5 Play latest call Q3 2026 earnings call transcript
Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$31.37B
Shares
174.78M
Volume · Nov 5 11.98M Avg daily vol (3M) 4.14M

Analyst Estimates

Compare analyst forecasts for Astera Labs, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-05 14:26 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
3.90
4.09
4.40
20
4.04
4.04
4.04
4.03
0
0
1
1
Revenue
USD
Publication date not stated
1.86B
1.92B
2.03B
20
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
4.45
6.57
9.02
22
6.41
6.39
6.39
6.26
0
0
1
1
Revenue
USD
Publication date not stated
2.19B
3.04B
3.68B
23
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.29
1.46
1.71
19
1.43
1.42
1.42
1.42
0
0
1
1
Revenue
USD
Publication date not stated
609.10M
666.66M
740.20M
17
 — — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.31
1.52
1.97
19
1.46
1.46
1.46
1.46
0
0
1
1
Revenue
USD
Publication date not stated
614.70M
707.75M
811.73M
17
 — — — — — — — —
Key facts CIK 1736297 CUSIP 04626A103 13F (30d) 457 filings 429 filers Visit website Investor relations